Patent · US Active

Cancer targets and uses thereof

US8168586B1 · kind B1 · utility

21Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 21, 2008
Grant dateMay 1, 2012
Priority date
Expiry dateMar 9, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/10
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Methods and compositions are provided for assessing, treating, and preventing diseases, especially cancer, using cancer-associated targets (“CAT”). Methods and compositions are also provided for determining or predicting the effectiveness of a treatment for these diseases or for selecting a treatment, using CAT. Methods and compositions are further provided for modulating cell function using CAT. Also provided are compositions that modulate CAT (e.g., antagonists or agonists), such as antibodies, proteins, small molecule compounds, and nucleic acid agents (e.g., RNAi and antisense agents), as well as pharmaceutical compositions thereof. Further provided are methods of screening for agents that modulate CAT, and agents identified by these screening methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.